Moderna's latest genomics move sees it team up with Life Edit to develop new gene editing therapies

One of Moderna's New Year's resolutions appears to have been to expand its genomics output. The latest move in this area sees the mRNA company pen a partnership with ElevateBio’s Life Edit Therapeutics with the aim of developing next-gen gene editing therapies for hard-to-treat diseases.